Paid Clinical Trials in New York

New York has 4,879 paid clinical trials enrolling now across cities including New York, The Bronx and Rochester. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in New York include Memorial Sloan Kettering, NYU Langone and Weill Cornell Medicine, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 17, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

4,284 clinical trials

Get a weekly email when new trials open in New York, NY.

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

for Neoplasms, Head and Neck

Drug: Dostarlimab

Sites in The Bronx +30 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06256588·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

for Non-obstructive Hypertrophic Cardiomyopathy

Sites in New York +21 more locations

Sponsor: Imbria Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07023614·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

for Pulmonary Sarcoidosis

Sites in New York +13 more locations

Sponsor: Xentria, Inc.

Sex: All·Age: 18 - 80

Code: NCT05890729·Phase 1, Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for Metastatic Non-small Cell Lung Cancer

Drug: Osimertinib

Sites in New York, The Bronx +25 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06417814·Phase 3·Recruiting·Listed May 2024

Apply to this trial

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

for Gastric Cancer

Sites in New York +3 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT05702229·Phase 2·Recruiting·Listed Jan 2023

Apply to this trial

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment

for Eosinophilic Asthma

Sites in The Bronx, New Hyde Park +29 more locations

Sponsor: AstraZeneca

Sex: All·Age: 12 - 75

Code: NCT06750289·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

for Metastatic Castration-Resistant Prostate Cancer

Sites in New York +11 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT06879041·Phase 1·Recruiting·Listed Mar 2025

Apply to this trial

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for Multiple Myeloma

Drug: Belantamab mafodotin

Sites in New York, Stony Brook +28 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06679101·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

for Urinary Tract Infections

Sites in Rochester +5 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18 - 64·Accepts healthy volunteers

Code: NCT06702449·Phase 1, Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

for Growth Hormone Deficiency

Sites in New Hyde Park +26 more locations

Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All·Age: All ages

Code: NCT05820672·Recruiting·Listed Apr 2023

Apply to this trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

for Cutaneous Lupus Erythematosus (CLE)

Sites in Fairport +12 more locations

Sponsor: Ventus Therapeutics U.S., Inc.

Sex: All·Age: 18 - 80

Code: NCT07260877·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

for Primary Myelofibrosis

Sites in New York +4 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06517875·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis

for Joint Infection

Sites in New York +2 more locations

Sponsor: Hospital for Special Surgery, New York

Sex: All·Age: Up to 17

Code: NCT03704766·Recruiting·Listed Oct 2018

Apply to this trial

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

for Pulmonary Disease, Chronic Obstructive

Drug: Depemokimab

Sites in Mount Kisco, New Windsor +53 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 40 - 80

Code: NCT06961214·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors

for Cancer-related Problem/Condition

1 location in New York

Sponsor: 5 Point App, Inc.

Sex: All·Age: 18+

Code: NCT06754722·Recruiting·Listed Jan 2025

Apply to this trial

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

for Solid Tumor

Sites in New York +6 more locations

Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female·Age: 18+

Code: NCT04516447·Phase 1·Recruiting·Listed Aug 2020

Apply to this trial

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

for Solid Tumor

Sites in New York +16 more locations

Sponsor: Biohaven Therapeutics Ltd.

Sex: All·Age: 18+

Code: NCT06384807·Phase 1, Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

for Hypertension

Sites in Rochester, Mount Kisco +26 more locations

Sponsor: Vanda Pharmaceuticals

Sex: All·Age: 18 - 65

Code: NCT07090161·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

Open-label Extension Study in Participants With Early Alzheimer's Disease

for Alzheimer's Disease

Sites in Staten Island +8 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 50 - 85

Code: NCT07105709·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

for Acute Respiratory Distress Syndrome

Sites in The Bronx, Flushing +30 more locations

Sponsor: Direct Biologics, LLC

Sex: All·Age: 18 - 75

Code: NCT05354141·Phase 3·Recruiting·Listed Apr 2022

Apply to this trial

Study of AZD0754 in Participants With Metastatic Prostate Cancer

for Metastatic Prostate Cancer

Sites in New York +12 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18 - 130

Code: NCT06267729·Phase 1, Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

for Growth Hormone Deficiency

Sites in New Hyde Park +26 more locations

Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All·Age: 1 - 18

Code: NCT05775523·Recruiting·Listed Mar 2023

Apply to this trial

Optimizing Reperfusion to Improve Outcomes and Neurologic Function

for Acute Ischemic Stroke

Sites in New York, Great Neck +15 more locations

Sponsor: Corxel Pharmaceuticals

Sex: All·Age: 18 - 90

Code: NCT06990867·Phase 2, Phase 3·Recruiting·Listed May 2025

Apply to this trial

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

for Colonic Neoplasms

Drug: Dostarlimab

Sites in New York, The Bronx +25 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT05855200·Phase 3·Recruiting·Listed May 2023

Apply to this trial

Randomized Withdrawal Study in Patients With Schizophrenia

for Schizophrenia

Sites in Staten Island +21 more locations

Sponsor: Vanda Pharmaceuticals

Sex: All·Age: 18 - 65

Code: NCT06961968·Phase 3·Recruiting·Listed May 2025

Apply to this trial

The Impact of Group Singing on Patients With Stroke and Their Personal Caregivers

for Stroke and Aphasia

1 location in New York

Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All·Age: 18+

Code: NCT02328573·Recruiting·Listed Dec 2014

Apply to this trial

Effect of Text Message Reminders on M-ISI Score After Prostate Surgery

for Incontinence, Urinary Stress

1 location in Rochester

Sponsor: University of Rochester

Sex: Male·Age: 18+

Code: NCT07071207·Recruiting·Listed Jul 2025

Apply to this trial

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

for Major Depressive Disorder (MDD)

Sites in New York, Staten Island +17 more locations

Sponsor: Vanda Pharmaceuticals

Sex: All·Age: 18 - 65

Code: NCT06830044·Phase 3·Recruiting·Listed Feb 2025

Apply to this trial

Study of ALTO-300 in MDD

for Major Depressive Disorder

Sites in Staten Island +37 more locations

Sponsor: Alto Neuroscience

Sex: All·Age: 18 - 70

Code: NCT05922878·Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

for Neoplasms

1 location in Lake Success

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT07277270·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

for Basal Cell Carcinoma

Sites in Rochester +9 more locations

Sponsor: Stamford Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT06344052·Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

A Clinical Trial Evaluating the Efficacy and Safety of Leflutrozole on Testicular Function

for Semen Quality

Sites in Garden City +3 more locations

Sponsor: ReproNovo Aps

Sex: Male·Age: 18 - 49

Code: NCT06993155·Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age

for Excessive Daytime Sleepiness

Sites in New York +2 more locations

Sponsor: Centessa Pharmaceuticals (UK) Limited

Sex: All·Age: 18 - 80·Accepts healthy volunteers

Code: NCT07082829·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

Study of ALTO-101 in Patients With Schizophrenia

for Schizophrenia

Sites in New York, White Plains +11 more locations

Sponsor: Alto Neuroscience

Sex: All·Age: 21 - 55

Code: NCT06502964·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

for Interstitial Lung Disease

Sites in New York +14 more locations

Sponsor: aTyr Pharma, Inc.

Sex: All·Age: 18+

Code: NCT05892614·Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

for Cataract

Sites in New York, Rochester +6 more locations

Sponsor: EyePoint Pharmaceuticals, Inc.

Sex: All·Age: Up to 3

Code: NCT05191706·Phase 4·Recruiting·Listed Jan 2022

Apply to this trial

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

for Thrombotic Microangiopathies

Sites in New York, Valhalla +6 more locations

Sponsor: Omeros Corporation

Sex: All·Age: 28 Days - 17

Code: NCT05855083·Phase 2·Recruiting·Listed May 2023

Apply to this trial

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

for Major Depressive Disorder

Sites in New York, Brooklyn +38 more locations

Sponsor: Axsome Therapeutics, Inc.

Sex: All·Age: 18 - 65

Code: NCT06223880·Phase 4·Recruiting·Listed Jan 2024

Apply to this trial